Search - tctmd.com

Displaying 361 - 380 of 470

Sort: Relevancy | Date

Presentation THT Abstracts 2024

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: William Abraham

March 04, 2024

Presentation THT Abstracts 2024

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Presenter: Fouad Sakr

March 04, 2024

Presentation THT Abstracts 2024

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

Presenter: Eduardo Arias

March 04, 2024

Presentation THT Abstracts 2024

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Presenter: Timothy George

March 04, 2024

Presentation THT Abstracts 2024

Role of Invasive Exercise Hemodynamics in Symptomatic Secondary Mitral Regurgitation Prior to Transcatheter Edge-to-Edge Repair

Presenter: Bassim El-Sabawi

March 04, 2024

Presentation THT Abstracts 2024

Pre-clinical results with a chronically-adjustable and pressure sensing interatrial shunt

Presenter: Liviu Klein

March 04, 2024

Presentation THT Abstracts 2024

Physician-Directed Patient Self-Management in HF using LA Pressure: Interim Insights from VECTOR-HF I and IIa Studies

Presenter: William Abraham

March 04, 2024

Presentation THT Abstracts 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

Presentation THT Abstracts 2024

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach †

Presenter: Kyung-Hee Kim

March 04, 2024

Presentation THT Abstracts 2024

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

Presenter: Amish Raval

March 04, 2024

Presentation THT Abstracts 2024

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients with Heart Failure and HIV disease-A Cross Sectional Study from Nationwide Readmission Database

Presenter: Badri Aryal

March 04, 2024

Presentation THT Abstracts 2024

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Presenter: Vivek Jha

March 04, 2024

Presentation THT Abstracts 2024

Hemodynamic Response Related to Stimulation of the Greater Splanchnic Nerve Pre- and Post- Ablation

Presenter: Luke Kim

March 04, 2024

Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

Presentation THT Abstracts 2024

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

Presenter: Ameesh Isath

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon Litwin

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Presenter: Marat Fudim

March 04, 2024

Presentation THT Abstracts 2024

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

Presenter: Marvin Konstam

March 04, 2024

Presentation THT Abstracts 2024

Effect of Expert Team Consultation for Adjustment of Guideline Directed Medical Therapy on Heart Failure Related Adverse Outcomes in Patients with Reduced Ejection Fraction

Presenter: Joseph Maenza

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Advertisement

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Role of Invasive Exercise Hemodynamics in Symptomatic Secondary Mitral Regurgitation Prior to Transcatheter Edge-to-Edge Repair

Pre-clinical results with a chronically-adjustable and pressure sensing interatrial shunt

Physician-Directed Patient Self-Management in HF using LA Pressure: Interim Insights from VECTOR-HF I and IIa Studies

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach †

Interim Results from Adaptive Randomized Controlled Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients with Ischemic Heart Failure due to Reduced Left Ventricular Ejection Fraction (HFrEF)

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients with Heart Failure and HIV disease-A Cross Sectional Study from Nationwide Readmission Database

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Hemodynamic Response Related to Stimulation of the Greater Splanchnic Nerve Pre- and Post- Ablation

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: REBALANCE-HF Stress Blood Volume Analysis †

Effect Of Vagal Nerve Stimulation On Quality Of Life, Functional Capacity, And Left Ventricular Function In Patients With Chronic Heart Failure: An Update On The ANTHEM-HFrEF Pivotal Study Results

Effect of Expert Team Consultation for Adjustment of Guideline Directed Medical Therapy on Heart Failure Related Adverse Outcomes in Patients with Reduced Ejection Fraction

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content